...
首页> 外文期刊>Biochemistry (Moscow). Supplement, Series A. Membrane and cell biology >The role of pannexin 1 in the purinergic regulation of synaptic transmission in mouse motor synapses
【24h】

The role of pannexin 1 in the purinergic regulation of synaptic transmission in mouse motor synapses

机译:Pannexin 1在小鼠电动机突触中突触传递的静脉能调节中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

AbstractThe role of pannexin 1 in the release to the extracellular space of ATP/adenosine modulating the acetylcholine (ACh) secretion was studied in mouse diaphragm motor synapses. Using neuromuscular preparations obtained from wild-type and pannexin-1 knockout mice, the miniature endplate potential (MEPPs) and evoked endplate potentials (EPPs) were recorded in combination with pharmacological modulation of P2-type ATP receptors and A1-type adenosine receptors. Selective inhibition of A1receptors with DPCPX or P2 receptors with PPADS increased quantal content of EPPs in wild-type mice. MRS 2211, selective antagonist of P2Y13 receptors, produced the same effect. Activation of receptors A1or P2Y13by their agonists (2-CADO and IDP, respectively) decreased the EPP quantal content. It means that the activity of endogenous ATP and adenosine is synergistic and directed to depression of the ACh release. ARL67156, an inhibitor of synaptic ecto-ATPases, which blocks the hydrolysis of ATP to adenosine and increases the level of ATP in the synaptic cleft, prolonged EPPs without changing their quantal content. In pannexin-1 knockout mice there were no changes in the EPP quantal content and in other parameters of synaptic transmission as compared to wildtype mice. However, downregulation of purinergic effects with antagonists of A1or P2 receptors (DPCPX, PPADS, MRS 2211) did not change EPP quantal content and any other parameters of spontaneous or evoked ACh release in all cases. ARL67156 did not alter the temporal parameters of EPPs, either. Nevertheless, 2-CADO, the A1-type receptor agonist, decreased the EPP quantal content, while the agonist of P2Y13receptors decreased the MEPP amplitude. Thus, in mice lacking pannexin 1, procedures revealing the presence and regulatory activity of synaptic ATP/adenosine did not change the parameters of synaptic transmission. The obtained data substantiate a mandatory role of pannexin 1 in the purinergic regulation of motor synapse activity by endogenous ATP/adenosine.]]>
机译:<![CDATA [ABARTAL ID =“ABS1”语言=“en”> <标题>抽象 ara> Pannexin 1在释放到ATP /腺苷调节乙酰胆碱的细胞外空间的角色(ACH )在小鼠隔膜电动机突触中研究了分泌物。使用从野生型和Pannexin-1敲除小鼠获得的神经肌肉制剂,与P2型ATP受体的药理学调制和<下标> 1的药理调制结合记录微型端板电位(MEPP)和诱发的端板电位(EPP)和诱发的底板电位(EPPS)。<下标> 1 型腺苷受体。具有PPAD的DPCPX或P2受体的选择性抑制<下标> 1 受体,具有PPAD在野生型小鼠中增加了EPP的量量含量。 2211夫人,P2Y13受体的选择性拮抗剂,产生了相同的效果。受体激活受体A <下标> 1 或P2Y <下标> 13 分别的激动剂(分别为2-CADO和IDP)降低了EPP量子内容。这意味着内源性ATP和腺苷的活性是协同的,并指向ACH释放的抑郁症。 ARL67156是突触胞外酶的抑制剂,其阻断ATP对腺苷的水解,并增加突触裂缝中的ATP水平,长期EPPS而不改变其量含量。在Pannexin-1敲除小鼠中,与野生型小鼠相比,EPP量子含量和其他参数突触传递的其他参数没有变化。然而,与<下标> 1 或P2受体的拮抗剂(DPCPX,PPAD,2211)的拮抗剂下调的嘌呤能效应未改变EPP量子含量和所有情况下的任何其他自发或诱发ACH的参数。 ARL67156也没有改变EPP的时间参数。然而,2-CADO,A <下标> 1 -TYPE受体激动剂降低了EPP量化含量,而P2Y <下标> 13 受体的激动剂降低了MEPP幅度。因此,在缺乏Pannexin的小鼠中,揭示突触ATP /腺苷的存在和调节活性的程序没有改变突触传递的参数。所获得的数据证实了Pannexin 1在通过内源ATP /腺苷的过静脉突触活性的嘌呤能调节中的强制性作用。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号